Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8228098 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 7 Pages |
Abstract
Early results with SBRT monotherapy and post-EBRT boost for PCa demonstrate acceptable PSA response and minimal toxicity. PSA nadir with SBRT boost appears comparable to those achieved with HDR brachytherapy boost.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Siavash M.D., Vivian K. Ph.D., Tania M.D., I-Chow M.D., Lijun Ph.D., Cynthia Ph.D., Martina Ph.D., Stephen M.D., Ph.D., Katsuto M.D., Mack M.D., Alexander R. M.D.,Ph.D.,